|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/13 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| C12N 15/62 | (2006.01) | ||
| C12N 15/70 | (2006.01) | ||
| C12N 1/21 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 1287140 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01934209.6 |
| Date of filing the European patent application | 2001-06-05 | |
| (97) | Date of publication of the European application | 2003-03-05 |
| (45) | Date of publication and mention of the grant of the patent | 2009-12-09 |
| (46) | Date of publication of the claims translation | 2010-04-26 |
| (86) | Number | PCT/GB2001/002477 |
| Date | 2001-06-05 |
| (87) | Number | WO 2001/094585 |
| Date | 2001-12-13 |
| (30) | Number | Date | Country code |
| 0013810 | 2000-06-06 | GB |
| (72) |
ATHWAL, Diljeet Singh, GB
BROWN, Derek Thomas, GB
WEIR, Andrew Neil Charles, GB
POPPLEWELL, Andrew George, GB
CHAPMAN, Andrew Paul, GB
KING, David John, GB
|
| (73) |
UCB Pharma, S.A.,
Allée de La Recherche 60, 1070 Brussels,
BE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūno molekulės, turinčios specifiškumą žmogaus auglio nekrozės faktoriui alfa ir jų panaudojimas |
| ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN TUMOR NECROSIS FACTOR ALPHA, AND USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2020-05-21 | 347.00 EUR |